Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Purpura, Thrombotic Thrombocytopenic

• Aspirin for Prophylaxis of TTP
• Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura
• Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP
• Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP
• Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia
• A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
• A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)
• Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
• Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care
• Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)
• Octaplas Adult TTP Trial
• A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura
• Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura
• Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)
• The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)
• Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
• Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)
• Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy
• Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)
• ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders
• Rituximab in Patients With Relapsed or Refractory TTP-HUS
• Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura